Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Carboplatin CMI 06 Dec 2019
Bicillin L-A PI 06 Dec 2019
Persantin SR PI 06 Dec 2019
Persantin SR CMI 06 Dec 2019
Aubagio CMI 06 Dec 2019

New products

Product name Type Date released
Rizatriptan ODT Apotex PI 05 Dec 2019
Rizatriptan ODT Apotex CMI 05 Dec 2019
Moxifloxacin APO PI 29 Nov 2019
Moxifloxacin APO CMI 29 Nov 2019
Sevelamer Apotex PI 28 Nov 2019